Statistical Review: Data quality and clinical trial design
Available from: Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Insulin resistance is a hallmark of type 2 diabetes and often precedes its development, where cells become less responsive to insulin's signal to take up glucose from the bloodstream
You will have scheduled check-ins to discuss how you are feeling, any side effects (which are typically minimal at microdose levels), changes in appetite or energy, and whether a dose adjustment is appropriate
When appropriate, they are prescribed only after individualized medical evaluation and filled by a licensed U.S
Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP